Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Dose-Escalation Study of T Cell Vaccine in Multiple Sclerosis

NCT00587691 is registered in ClinicalTrials.gov with Opexa Therapeutics, Inc. as lead sponsor.

NCT NCT00587691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00587691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Dose-Escalation Study of T Cell Vaccine in Multiple Sclerosis
Lead sponsor
Opexa Therapeutics, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
July 31, 2002
Completion date
December 31, 2008
Enrollment
16 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, relapsing-remitting, multiple sclerosis, secondary progressive